Home/Filings/4/0001213900-20-008214
4//SEC Filing

Bell John K 4

Accession 0001213900-20-008214

CIK 0001498382other

Filed

Mar 30, 8:00 PM ET

Accepted

Mar 31, 4:15 PM ET

Size

5.5 KB

Accession

0001213900-20-008214

Insider Transaction Report

Form 4
Period: 2020-03-31
Bell John K
Director
Transactions
  • Other

    Common Stock

    2020-03-31+299,788 total(indirect: Held by Onbelay Capital Inc.)
Holdings
  • Common Stock

    (indirect: Held by Registered Retirement Income Fund)
    35,000
Footnotes (1)
  • [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.

Documents

1 file

Issuer

DelMar Pharmaceuticals, Inc.

CIK 0001498382

Entity typeother

Related Parties

1
  • filerCIK 0001569585

Filing Metadata

Form type
4
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 4:15 PM ET
Size
5.5 KB